Inhaled dosage form of BAL30072 to be formulated for patients with cystic fibrosis
Basilea is to work with the iABC consortium to develop…
7 September 2015 | By Victoria White
Basilea is to work with the iABC consortium to develop an inhaled formulation of its antibiotic BAL30072 as part of a new Europe-wide programme...